Do saturated fatty acids have the same metabolic effect?;Tous les acides gras saturés ont-ils le même effet métabolique?

Nutrition Clinique et Metabolisme

Volumn 24, Issue 2, 2010, Pages 63-75

  Walrand, Stéphane ^a   Fisch, François ^b   Bourre, Jean Marie ^b  

^a INRA and University of Auvergne   (France)

^b NONE   (France)

Author keywords

Cardiovascular disease; Insulin resistance; Metabolic sydrome; Palm oil; Palmitic acid; Saturated fatty acid

Indexed keywords

ARACHIS OIL; CYTOKINE; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PALM OIL; PALMITIC ACID; SATURATED FATTY ACID; STEARIC ACID; TRIACYLGLYCEROL;

ADIPOSE TISSUE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CELL TYPE; CHOLESTEROL BLOOD LEVEL; CYTOKINE PRODUCTION; DIETARY INTAKE; DISEASE EXACERBATION; HORMONE ACTION; HUMAN; INFLAMMATION; INSULIN RESISTANCE; LIPID STORAGE; MEDIATOR RELEASE; METABOLIC DISORDER; METABOLIC SYNDROME X; NONHUMAN; POSTPRANDIAL STATE; REVIEW; RISK FACTOR; SKELETAL MUSCLE; TISSUE METABOLISM;

ARACHIS HYPOGAEA;

EID: 77952958847     PISSN: 09850562     EISSN: 17683092     Source Type: Journal    
DOI: 10.1016/j.nupar.2010.02.003     Document Type: Review

References (120)

1. Hunter J.E. Food fats and oils. Prog Clin Biol Res 1986, 222:153-184.
2. Hunter J.E., Applewhite T.H. Isomeric fatty acids in the US diet: levels and health perspectives. Am J Clin Nutr 1986, 44:707-717.
3. Garg A., Fleckenstein J.L., Peshock R.M., Grundy S.M. Peculiar distribution of adipose tissue in patients with congenital generalized lipodystrophy. J Clin Endocrinol Metab 1992, 75:358-361.
4. Coppack S.W., Jensen M.D., Miles J.M. In vivo regulation of lipolysis in humans. J Lipid Res 1994, 35:177-193.
5. Bjorntorp P., Bergman H., Varnauskas E. Plasma free fatty acid turnover rate in obesity. Acta Med Scand 1969, 185:351-356.
6. Gordon R.S. Metabolism of serum-free fatty acids. Fed Proc 1960, 19(Suppl. 5):120-121.
7. Jensen M.D., Haymond M.W., Rizza R.A., Cryer P.E., Miles J.M. Influence of body fat distribution on free fatty acid metabolism in obesity. J Clin Invest 1989, 83:1168-1173.
8. Abate N., Garg A., Peshock R.M., Stray-Gundersen J., Grundy S.M. Relationships of generalized and regional adiposity to insulin sensitivity in men. J Clin Invest 1995, 96:88-98.
9. McGarry J.D., Foster D.W. Systemic carnitine deficiency. N Engl J Med 1980, 303:1413-1415.
10. Murthy M.S., Pande S.V. Some differences in the properties of carnitine palmitoyltransferase activities of the mitochondrial outer and inner membranes. Biochem J 1987, 248:727-733.
11. McGarry J.D., Sen A., Esser V., Woeltje K.F., Weis B., Foster D.W. New insights into the mitochondrial carnitine palmitoyltransferase enzyme system. Biochimie 1991, 73:77-84.
12. McGarry J.D., Foster D.W. Regulation of hepatic fatty acid oxidation and ketone body production. Annu Rev Biochem 1980, 49:395-420.
13. Morris A.A. Cerebral ketone body metabolism. J Inherit Metab Dis 2005, 28:109-121.
14. Tijburg L.B., Samborski R.W., Vance D.E. Evidence that remodeling of the fatty acids of phosphatidylcholine is regulated in isolated rat hepatocytes and involves both the sn-1 and sn-2 positions. Biochim Biophys Acta 1991, 1085:184-190.
15. Jeukendrup A.E. Dietary fat and physical performance. Curr Opin Clin Nutr Metab Care 1999, 2:521-526.
16. Belmonte M.A., Aoki M.S., Tavares F.L., Seelaender M.C. Rat myocellular and perimysial intramuscular triacylglycerol: a histological approach. Med Sci Sports Exerc 2004, 36:60-67.
17. Langfort J., Donsmark M., Ploug T., Holm C., Galbo H. Hormone-sensitive lipase in skeletal muscle: regulatory mechanisms. Acta Physiol Scand 2003, 178:397-403.
18. Shulman G.I. Cellular mechanisms of insulin resistance. J Clin Invest 2000, 106:171-176.
19. Dresner A., Laurent D., Marcucci M., Griffin M.E., Dufour S., Cline G.W., et al. Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity. J Clin Invest 1999, 103:253-259.
20. Roden M., Krssak M., Stingl H., Gruber S., Hofer A., Furnsinn C., et al. Rapid impairment of skeletal muscle glucose transport/phosphorylation by free fatty acids in humans. Diabetes 1999, 48:358-364.
21. Sinha S., Perdomo G., Brown N.F., O'Doherty R.M. Fatty acid-induced insulin resistance in L6 myotubes is prevented by inhibition of activation and nuclear localization of nuclear factor kappa B. J Biol Chem 2004, 279:41294-41301.
22. Yuan M., Konstantopoulos N., Lee J., Hansen L., Li Z.W., Karin M., et al. Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta. Science 2001, 293:1673-1677.
23. Hirosumi J., Tuncman G., Chang L., Gorgun C.Z., Uysal K.T., Maeda K., et al. A central role for JNK in obesity and insulin resistance. Nature 2002, 420:333-336.
24. Bennett B.L., Satoh Y., Lewis A.J. JNK: a new therapeutic target for diabetes. Curr Opin Pharmacol 2003, 3:420-425.
25. Kim J.K., Kim Y.J., Fillmore J.J., Chen Y., Moore I., Lee J., et al. Prevention of fat-induced insulin resistance by salicylate. J Clin Invest 2001, 108:437-446.
26. Turinsky J., Bayly B.P., O'Sullivan D.M. 1,2-Diacylglycerol and ceramide levels in rat skeletal muscle and liver in vivo. Studies with insulin, exercise, muscle denervation, and vasopressin. J Biol Chem 1990, 265:7933-7938.
27. Adams J.M., Pratipanawatr T., Berria R., Wang E., DeFronzo R.A., Sullards M.C., et al. Ceramide content is increased in skeletal muscle from obese insulin-resistant humans. Diabetes 2004, 53:25-31.
28. Straczkowski M., Kowalska I., Nikolajuk A., Dzienis-Straczkowska S., Kinalska I., Baranowski M., et al. Relationship between insulin sensitivity and sphingomyelin signaling pathway in human skeletal muscle. Diabetes 2004, 53:1215-1221.
29. Gorski J., Dobrzyn A., Zendzian-Piotrowska M. The sphingomyelin-signaling pathway in skeletal muscles and its role in regulation of glucose uptake. Ann N Y Acad Sci 2002, 967:236-248.
30. Chavez J.A., Knotts T.A., Wang L.P., Li G., Dobrowsky R.T., Florant G.L., et al. A role for ceramide, but not diacylglycerol, in the antagonism of insulin signal transduction by saturated fatty acids. J Biol Chem 2003, 278:10297-10303.
31. Chavez J.A., Summers S.A. Characterizing the effects of saturated fatty acids on insulin signaling and ceramide and diacylglycerol accumulation in 3T3-L1 adipocytes and C2C12 myotubes. Arch Biochem Biophys 2003, 419:101-109.
32. Hajduch E., Balendran A., Batty I.H., Litherland G.J., Blair A.S., Downes C.P., et al. Ceramide impairs the insulin-dependent membrane recruitment of protein kinase B leading to a loss in downstream signalling in L6 skeletal muscle cells. Diabetologia 2001, 44:173-183.
33. Schmitz-Peiffer C., Craig D.L., Biden T.J. Ceramide generation is sufficient to account for the inhibition of the insulin-stimulated PKB pathway in C2C12 skeletal muscle cells pretreated with palmitate. J Biol Chem 1999, 274:24202-24210.
34. Summers S.A., Garza L.A., Zhou H., Birnbaum M.J. Regulation of insulin-stimulated glucose transporter GLUT4 translocation and Akt kinase activity by ceramide. Mol Cell Biol 1998, 18:5457-5464.
35. Teruel T., Hernandez R., Lorenzo M. Ceramide mediates insulin resistance by tumor necrosis factor-alpha in brown adipocytes by maintaining Akt in an inactive dephosphorylated state. Diabetes 2001, 50:2563-2571.
36. Powell D.J., Turban S., Gray A., Hajduch E., Hundal H.S. Intracellular ceramide synthesis and protein kinase Czeta activation play an essential role in palmitate-induced insulin resistance in rat L6 skeletal muscle cells. Biochem J 2004, 382:619-629.
37. Magnan C. Lipotoxicité et insulino-résistance. Nutr Clin Métabol 2006, 20(2):108-113.
38. Yki-Jarvinen H., Westerbacka J. The fatty liver and insulin resistance. Curr Mol Med 2005, 5:287-295.
39. Nguyen M.T., Satoh H., Favelyukis S., Babendure J.L., Imamura T., Sbodio J.I., et al. JNK and tumor necrosis factor-alpha mediate free fatty acid-induced insulin resistance in 3T3-L1 adipocytes. J Biol Chem 2005, 280:35361-35371.
40. Engeli S., Bohnke J., Feldpausch M., Gorzelniak K., Heintze U., Janke J., et al. Regulation of 11beta-HSD genes in human adipose tissue: influence of central obesity and weight loss. Obes Res 2004, 12:9-17.
41. Kannisto K., Pietilainen K.H., Ehrenborg E., Rissanen A., Kaprio J., Hamsten A., et al. Overexpression of 11beta-hydroxysteroid dehydrogenase-1 in adipose tissue is associated with acquired obesity and features of insulin resistance: studies in young adult monozygotic twins. J Clin Endocrinol Metab 2004, 89:4414-4421.
42. Melanson E.L., Gozansky W.S., Barry D.W., Maclean P.S., Grunwald G.K., Hill J.O. When energy balance is maintained, exercise does not induce negative fat balance in lean sedentary, obese sedentary, or lean endurance-trained individuals. J Appl Physiol 2009, 107:1847-1856.
43. Feskens E.J., Virtanen S.M., Rasanen L., Tuomilehto J., Stengard J., Pekkanen J., et al. Dietary factors determining diabetes and impaired glucose tolerance. A 20-year follow-up of the Finnish and Dutch cohorts of the Seven Countries Study. Diabetes Care 1995, 18:1104-1112.
44. Meyer K.A., Kushi L.H., Jacobs D.R., Folsom A.R. Dietary fat and incidence of type 2 diabetes in older Iowa women. Diabetes Care 2001, 24:1528-1535.
45. Salmeron J., Hu F.B., Manson J.E., Stampfer M.J., Colditz G.A., Rimm E.B., et al. Dietary fat intake and risk of type 2 diabetes in women. Am J Clin Nutr 2001, 73:1019-1026.
46. van Dam R.M., Rimm E.B., Willett W.C., Stampfer M.J., Hu F.B. Dietary patterns and risk for type 2 diabetes mellitus in US men. Ann Intern Med 2002, 136:201-209.
47. Maron D.J., Fair J.M., Haskell W.L. Saturated fat intake and insulin resistance in men with coronary artery disease. The Stanford Coronary Risk Intervention Project Investigators and Staff. Circulation 1991, 84:2020-2027.
48. Xiao C., Giacca A., Carpentier A., Lewis G.F. Differential effects of monounsaturated, polyunsaturated and saturated fat ingestion on glucose-stimulated insulin secretion, sensitivity and clearance in overweight and obese, non-diabetic humans. Diabetologia 2006, 49:1371-1379.
49. Heine R.J., Mulder C., Popp-Snijders C., van der Meer J., van der Veen E.A. Linoleic-acid-enriched diet: long-term effects on serum lipoprotein and apolipoprotein concentrations and insulin sensitivity in noninsulin-dependent diabetic patients. Am J Clin Nutr 1989, 49:448-456.
50. Summers L.K., Fielding B.A., Bradshaw H.A., Ilic V., Beysen C., Clark M.L., et al. Substituting dietary saturated fat with polyunsaturated fat changes abdominal fat distribution and improves insulin sensitivity. Diabetologia 2002, 45:369-377.
51. Christiansen E., Schnider S., Palmvig B., Tauber-Lassen E., Pedersen O. Intake of a diet high in trans monounsaturated fatty acids or saturated fatty acids. Effects on postprandial insulinemia and glycemia in obese patients with NIDDM. Diabetes Care 1997, 20:881-887.
52. Esposito K., Nappo F., Marfella R., Giugliano G., Giugliano F., Ciotola M., et al. Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation 2002, 106:2067-2072.
53. Nappo F., Esposito K., Cioffi M., Giugliano G., Molinari A.M., Paolisso G., et al. Postprandial endothelial activation in healthy subjects and in type 2 diabetic patients: role of fat and carbohydrate meals. J Am Coll Cardiol 2002, 39:1145-1150.
54. Borst S.E., Conover C.F. High-fat diet induces increased tissue expression of TNF-alpha. Life Sci 2005, 77:2156-2165.
55. Trayhurn P. Adipose tissue in obesity--an inflammatory issue. Endocrinology 2005, 146:1003-1005.
56. Bullo M., Garcia-Lorda P., Megias I., Salas-Salvado J. Systemic inflammation, adipose tissue tumor necrosis factor, and leptin expression. Obes Res 2003, 11:525-531.
57. Engstrom G., Hedblad B., Stavenow L., Lind P., Janzon L., Lindgarde F. Inflammation-sensitive plasma proteins are associated with future weight gain. Diabetes 2003, 52:2097-2101.
58. Festa A., D'Agostino R., Williams K., Karter A.J., Mayer-Davis E.J., Tracy R.P., et al. The relation of body fat mass and distribution to markers of chronic inflammation. Int J Obes Relat Metab Disord 2001, 25:1407-1415.
59. Yudkin J.S. Adipose tissue, insulin action and vascular disease: inflammatory signals. Int J Obes Relat Metab Disord 2003, 27(Suppl. 3):S25-28.
60. Wellen K.E., Hotamisligil G.S. Inflammation, stress, and diabetes. J Clin Invest 2005, 115:1111-1119.
61. Wang B., Jenkins J.R., Trayhurn P. Expression and secretion of inflammation-related adipokines by human adipocytes differentiated in culture: integrated response to TNF-alpha. Am J Physiol Endocrinol Metab 2005, 288:E731-740.
62. Bajaj M., Suraamornkul S., Piper P., Hardies L.J., Glass L., Cersosimo E., et al. Decreased plasma adiponectin concentrations are closely related to hepatic fat content and hepatic insulin resistance in pioglitazone-treated type 2 diabetic patients. J Clin Endocrinol Metab 2004, 89:200-206.
63. Ajuwon K.M., Spurlock M.E. Palmitate activates the NF-kappaB transcription factor and induces IL-6 and TNFalpha expression in 3T3-L1 adipocytes. J Nutr 2005, 135:1841-1846.
64. Ciapaite J., van Bezu J., van Eikenhorst G., Bakker S.J., Teerlink T., Diamant M., et al. Palmitate and oleate have distinct effects on the inflammatory phenotype of human endothelial cells. Biochim Biophys Acta 2007, 1771:147-154.
65. Weigert C., Brodbeck K., Staiger H., Kausch C., Machicao F., Haring H.U., et al. Palmitate, but not unsaturated fatty acids, induces the expression of interleukin-6 in human myotubes through proteasome-dependent activation of nuclear factor-kappaB. J Biol Chem 2004, 279:23942-23952.
66. Jove M., Planavila A., Sanchez R.M., Merlos M., Laguna J.C., Vazquez-Carrera M. Palmitate induces tumor necrosis factor-alpha expression in C2C12 skeletal muscle cells by a mechanism involving protein kinase C and nuclear factor-kappaB activation. Endocrinology 2006, 147:552-561.
67. De Bandt J.P. Nutrition et obésité. Nutr Clin Metabol 2004, 18(3):147-155.
68. Xu H.E., Lambert M.H., Montana V.G., Parks D.J., Blanchard S.G., Brown P.J., et al. Molecular recognition of fatty acids by peroxisome proliferator-activated receptors. Mol Cell 1999, 3:397-403.
69. Parrish C.C., Pathy D.A., Angel A. Dietary fish oils limit adipose tissue hypertrophy in rats. Metabolism 1990, 39:217-219.
70. Raclot T., Groscolas R., Langin D., Ferre P. Site-specific regulation of gene expression by n-3 polyunsaturated fatty acids in rat white adipose tissues. J Lipid Res 1997, 38:1963-1972.
71. Tardif N., Salles J., Guillet C., Giraudet C., Rousset P., Patrac V., et al. L'invalidation du gène du TNFa augmente les capacités de stockage du tissu adipeux: un effet protecteur contre un régime obésogène ?. Nutr Clin Métabol 2009, 23:25.
72. Tardif N., Salles J., Guillet C., Rousset P., Giraudet C., Patrac V., et al. Un régime hyperlipidique/hypercalorique entraîne une diminution de la vitesse de synthèse protéique musculaire: une défaillance du tissu adipeux ?. Nutr Clin Metabol 2008, 22:135-136.
73. Tardif N, Salles J, Guillet C, Rousset P, Giraudet C, Patrac V, et al. The increased sensitivity to deleterious effects of high fat diet in old rats is related to an increase in muscle ceramide levels during aging. The 17th European Congress on Obesity, Amsterdam, 2009 (Communication Orale).
74. Tardif N., Salles J., Guillet C., Rousset P., Giraudet C., Patrac V., et al. Effet de la qualité des acides gras présents dans un régime hyperlipidique sur la sensibilité à l'insuline et la synthèse protéique musculaire du rat âgé. Nutr Clin Metabol 2008, 22:138.
75. Dunstan D.W., Salmon J., Owen N., Armstrong T., Zimmet P.Z., Welborn T.A., et al. Associations of TV viewing and physical activity with the metabolic syndrome in Australian adults. Diabetologia 2005, 48:2254-2261.
76. Rana J.S., Visser M.E., Arsenault B.J., Despres J.P., Stroes E.S., Kastelein J.J., et al. Metabolic dyslipidemia and risk of future coronary heart disease in apparently healthy men and women: The EPIC-Norfolk prospective population study. Int J Cardiol 2009, Sous presse.
77. Isomaa B., Almgren P., Tuomi T., Forsen B., Lahti K., Nissen M., et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001, 24:683-689.
78. Krauss R.M., Eckel R.H., Howard B., Appel L.J., Daniels S.R., Deckelbaum R.J., et al. AHA Dietary Guidelines: revision 2000: A statement for healthcare professionals from the Nutrition Committee of the American Heart Association. Circulation 2000, 102:2284-2299.
79. Nagao K., Yanagita T. Bioactive lipids in metabolic syndrome. Prog Lipid Res 2008, 47:127-146.
80. Joshi-Barve S., Barve S.S., Amancherla K., Gobejishvili L., Hill D., Cave M., et al. Palmitic acid induces production of proinflammatory cytokine interleukin-8 from hepatocytes. Hepatology 2007, 46:823-830.
81. Feldstein A.E., Werneburg N.W., Canbay A., Guicciardi M.E., Bronk S.F., Rydzewski R., et al. Free fatty acids promote hepatic lipotoxicity by stimulating TNF-alpha expression via a lysosomal pathway. Hepatology 2004, 40:185-194.
82. Solini A., Santini E., Ferrannini E. Effect of short-term folic acid supplementation on insulin sensitivity and inflammatory markers in overweight subjects. Int J Obes (Lond) 2006, 30:1197-1202.
83. Allagnat F., Alonso F., Martin D., Abderrahmani A., Waeber G., Haefliger J.A. ICER-1gamma overexpression drives palmitate-mediated connexin36 down-regulation in insulin-secreting cells. J Biol Chem 2008, 283:5226-5234.
84. Anand R.G., Peters R.W., Donahue T.P. Obesity and dysrhythmias. J Cardiometab Syndr 2008, 3:149-154.
85. Lusis A.J. Atherosclerosis. Nature 2000, 407:233-241.
86. Leopold J.A., Loscalzo J. Clinical importance of understanding vascular biology. Cardiol Rev 2000, 8:115-123.
87. Nickenig G., Wolff M., Stablein A., Pfister H., Bohm M. Enhanced expression and autoimmunity of recombination signal binding protein-jkappa in human dilated cardiomyopathy. Biochem Biophys Res Commun 1999, 266:432-436.
88. Kannel W.B., Gordon T., Schwartz M.J. Systolic versus diastolic blood pressure and risk of coronary heart disease. The Framingham study. Am J Cardiol 1971, 27:335-346.
89. Downs J.R., Clearfield M., Weis S., Whitney E., Shapiro D.R., Beere P.A., et al. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study. JAMA 1998, 279:1615-1622.
90. Pfeffer M.A., Sacks F.M., Moye L.A., Brown L., Rouleau J.L., Hartley L.H., et al. Cholesterol and Recurrent Events: a secondary prevention trial for normolipidemic patients. CARE Investigators. Am J Cardiol 1995, 76:98C-106C.
91. Shepherd J., Cobbe S.M., Ford I., Isles C.G., Lorimer A.R., MacFarlane P.W., et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N Engl J Med 1995, 333:1301-1307.
92. Castetbon K., Vernay M., Malon A., Salanave B., Deschamps V., Roudier C., et al. Dietary intake, physical activity and nutritional status in adults: the French nutrition and health survey (ENNS, 2006-2007). Br J Nutr 2009, 102:733-743.
93. Goldstein R.E., Michaelis L.L., Morrow A.G., Epstein S.E. Coronary collateral function in patients without occlusive coronary artery disease. Circulation 1975, 51:118-125.
94. Libby P. Inflammation in atherosclerosis. Nature 2002, 420:868-874.
95. Assmann G., Schulte H., Cullen P. New and classical risk factors--the Munster heart study (PROCAM). Eur J Med Res 1997, 2:237-242.
96. LaRosa J.C., Grundy S.M., Waters D.D., Shear C., Barter P., Fruchart J.C., et al. Intensive lipid lowering with atorvastatin in patients with stable coronary disease. N Engl J Med 2005, 352:1425-1435.
97. Dubois V., Breton S., Linder M., Fanni J., Parmentier M. Fatty acid profiles of 80 vegetable oils with regard to their nutritional potential. Eur J Lipid Sci Technol 2007, 109:710-732.
98. Kris-Etherton P.M., Yu S., Etherton T.D., Morgan R., Moriarty K., Shaffer D. Fatty acids and progression of coronary artery disease. Am J Clin Nutr 1997, 65:1088-1090.
99. Grundy S.M., Denke M.A. Dietary influences on serum lipids and lipoproteins. J Lipid Res 1990, 31:1149-1172.
100. Legrand P. Les acides gras: structure, fonctions, apports nutritionnels conseillés. Cah Nutr Diet 2007, 42:7-12.
101. Berry S.E. Triacylglycerol structure and interesterification of palmitic and stearic acid-rich fats: an overview and implications for cardiovascular disease. Nutr Res Rev 2009, 22:3-17.
102. Denke M.A., Grundy S.M. Effects of fats high in stearic acid on lipid and lipoprotein concentrations in men. Am J Clin Nutr 1991, 54:1036-1040.
103. Zock P.L., de Vries J.H., de Fouw N.J., Katan M.B. Positional distribution of fatty acids in dietary triglycerides: effects on fasting blood lipoprotein concentrations in humans. Am J Clin Nutr 1995, 61:48-55.
104. Nestel P.J., Noakes M., Belling G.B., McArthur R., Clifton P.M. Effect on plasma lipids of interesterifying a mix of edible oils. Am J Clin Nutr 1995, 62:950-955.
105. Keys A., Menotti A., Karvonen M.J., Aravanis C., Blackburn H., Buzina R., et al. The diet and 15-year death rate in the seven countries study. Am J Epidemiol 1986, 124:903-915.
106. Kromhout D., Menotti A., Bloemberg B., Aravanis C., Blackburn H., Buzina R., et al. Dietary saturated and trans fatty acids and cholesterol and 25-year mortality from coronary heart disease: the Seven Countries Study. Prev Med 1995, 24:308-315.
107. Hu F.B., Stampfer M.J., Manson J.E., Rimm E., Colditz G.A., Rosner B.A., et al. Dietary fat intake and the risk of coronary heart disease in women. N Engl J Med 1997, 337:1491-1499.
108. Jakobsen M.U., Overvad K., Dyerberg J., Schroll M., Heitmann B.L. Dietary fat and risk of coronary heart disease: possible effect modification by gender and age. Am J Epidemiol 2004, 160:141-149.
109. Kabagambe E.K., Baylin A., Siles X., Campos H. Individual saturated fatty acids and nonfatal acute myocardial infarction in Costa Rica. Eur J Clin Nutr 2003, 57:1447-1457.
110. Hjermann I., Holme I., Leren P. Oslo study diet and antismoking trial. Results after 102 months. Am J Med 1986, 80:7-11.
111. Hjermann I., Velve Byre K., Holme I., Leren P. Effect of diet and smoking intervention on the incidence of coronary heart disease. Report from the Oslo Study Group of a randomised trial in healthy men. Lancet 1981, 2:1303-1310.
112. de Lorgeril M., Renaud S., Mamelle N., Salen P., Martin J.L., Monjaud I., et al. Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease. Lancet 1994, 343:1454-1459.
113. Howell W.H., McNamara D.J., Tosca M.A., Smith B.T., Gaines J.A. Plasma lipid and lipoprotein responses to dietary fat and cholesterol: a meta-analysis. Am J Clin Nutr 1997, 65:1747-1764.
114. Mensink R.P., Zock P.L., Kester A.D., Katan M.B. Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials. Am J Clin Nutr 2003, 77:1146-1155.
115. Hegsted D.M., McGandy R.B., Myers M.L., Stare F.J. Quantitative effects of dietary fat on serum cholesterol in man. Am J Clin Nutr 1965, 17:281-295.
116. Grande F., Anderson J.T., Keys A. Comparison of effects of palmitic and stearic acids in the diet on serum cholesterol in man. Am J Clin Nutr 1970, 23:1184-1193.
117. Grundy S.M. Cholesterol and coronary heart disease. Future directions. JAMA 1990, 264:3053-3059.
118. Kim J.K., Kim Y.J., Fillmore J.J., Chen Y., Moore I., Lee J., Yuan M., Li Z.W., Karin M., Perret P., Shoelson S.E., Shulman G.I. Prevention of fat-induced insulin resistance by salicylate. J Clin Invest 2001, 108(3):437-446.
119. Ailhaud G., Teboul M., Massiera F. Angiotensinogen, adipocyte differentiation and fat mass enlargement. Curr Opin Clin Nutr Metab Care 2002, 5(4):385-389.
120. Nagao K., Yanagita T. Bioactive lipids in metabolic syndrome. Prog Lipid Res 2008, 47(2):127-146.